US 7,597,896 B2Granted

Composition comprising a protein encoded by a modified ERP gene of Mycobacterium

AssigneeInstitut Pasteur

InventorsBrigitte Gicquel, François-Xavier Berthet

Life of this patent

Estimating the term…

Abstract

The invention concerns Mycobacterium strains whereof the erp gene is modified and a vaccine composition containing same. The modification of the erp gene decreases the virulence and the persistence of the Mycobacterium strains.

Claims6

Dependent claims

Purified recombinant Mycobacterial ERP protein.

Dependencies are inferred from the claim text.

Facts

Application: 11/339,502Filed 26 Jan 2006 · division
Priority: FR 97 0930322 Jul 1997
Published: US 2006/0115497 A11 Jun 2006
Granted: 6 Oct 2009
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07K 14/35
From bacteria: from Mycobacteriaceae
A61K 39/00
Medicinal preparations containing antigens or antibodies
A61K 2039/522
Bacterial cells; Fungal cells; Protozoal cells: avirulent or attenuated
C07K
Peptides

Family

PCT/FR98/01627Parent of this continuation · filed 22 Jul 1998
Application10/259,460Parent of this division · filed 30 Sep 2002
US 2006/0115497 A1Pre-grant publication · published 1 Jun 2006
US 7,160,548 B2Parent of this division
Application09/463,194Parent of this continuation
US 6,585,976 B1Parent of this continuation
Application10/259,460Parent of this continuation
US 2003/0091597 A1Published application
US 7,597,896 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results